// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Management of adnexal masses identified during pregnancy

J. Barcroft - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fetal growth rate and cerebral blood flow redistribution in suspected late fetal growth restriction

T. Stampalija - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prenatal screening for 22q11.2DS: does it change patient care?

K. Martin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Velocardiofacial syndrome

N/A

Prenatal screening and testing for 45,X: lessons learned from 18,299 cfDNA results from the SMART study

K. Martin - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Point-of-care testing in pregnancy of unknown location outcome prediction

C. Kyriacou - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Conservative versus medical management of retained products of conception

S. Mitchell - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Misoprostol

Fibroids and the risk of miscarriage: prospective observational study

A. Vasireddy - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Spontaneous abortion

N/A

The assessment of microRNA as a novel biomarker in pregnancy of unknown location outcome prediction and ectopic pregnancy diagnosis

C. Kyriacou - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

N/A

Maternal hemodynamic changes among pregnant women with reduced fetal movements: results of the pilot study of FEMINA III

O. Coleman - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Slow growth, versus small for gestational age, at the last scan as predictors of stillbirth risk

O. Hugh - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PAN-COVID study: factors associated with preterm delivery in women with SARS-CoV-2 infection in pregnancy

E.W. Mullins - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Twin-specific customised GROW versus uncustomised STORK fetal weight standards: stillbirth risk versus small for gestational age at birth in subgroups according to maternal size

O. Hugh - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in maternal cardiac function during pregnancy among women with twin pregnancies

E. Smith - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Twin–twin transfusion syndrome

N/A

Fetal growth in twins: twin-specific versus singleton customised growth charts and stillbirth risk

O. Hugh - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Deep learning-based assessment of second trimester cortical plate development in three-dimensional ultrasound

M.K. Wyburd - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Automated grading of fetal cortical development using deep learning algorithms: a preliminary three-dimensional ultrasound study in healthy fetuses

M.K. Wyburd - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The clinical impact of antenatal diagnosis of single left superior vena cava: a retrospective review

G. Leonard - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Maternal and fetal Doppler in low-risk term pregnancy in early labour: can we screen for intrapartum fetal distress leading to obstetric intervention?

A. Dall'Asta - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fertility-sparing surgery and borderline ovarian tumours: oncological and fertility outcomes from a UK London gynecological oncology centre

L. Kasaven - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Estradiol and progesterone influence maternal cardiovascular parameters during fresh and frozen in vitro fertilisation

R. Jaspal - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alora

Copyright © 2026. QuantiNova All rights reserved